Skip to main content

All Articles

Choosing Among PARP Inhibitors as Maintenance Therapy in Ovarian Cancer
Amina Ahmed, MD, Paula Anastasia, RN, MN, AOCN and Ali McBride, PharmD, describe their experiences in the use of niraparib, olaparib and nucaparib as first-line maintenance therapy in Ovarian Cancer. Read More ›

It is a Herculean effort to develop a novel vaccine on an unprecedented timeline. Experts discuss the latest research regarding the development of vaccine candidates for the COVID-19 virus and some of the issues that will need to be addressed when a successful candidate has been identified, including clinical trial enrollment, manufacturing, and distribution. Read More ›

Community oncology practices say they are recovering from the COVID-19 pandemic and keeping their eye on the goal of value-based care. The strategies they are using to accomplish these initiatives include innovation, long-term integration of telehealth, and the leveraging of advanced practice professionals. Read More ›

The COVID-19 pandemic has created significant barriers to care, which can lead to increased mortality rates for thousands of patients with cancer. Nurses and nurse navigators are focused on using their skills and experience to combat this trend. Ongoing efforts include educating patients on the importance of undergoing cancer screenings, utilizing telehealth services to enhance communication with patients, addressing staffing shortages, and taking the necessary steps for preparing for potential spikes in COVID-19 cases. Read More ›

Can the use of telehealth services help to address the upcoming burden of late cancer diagnoses, improve the co-management of chronic conditions, and give patients more power over their own health? During a recent AVBCC webinar, a panel of experts explored this question as they discussed the potential role of wearables, remote monitoring and communication, and other innovative technology for improving care for patients with cancer. Read More ›

From the management of extended payment terms and performance-based agreements, to the potential impact of the proposed 2021 Medicare rules and the impending shortages of immune globulin, wholesale suppliers discuss how the COVID-19 pandemic continues to affect the oncology supply chain, what is being done to help practices, and what challenges lie ahead. Read More ›

Although several of the financial indicators in oncology have recovered to pre-pandemic levels following dramatic declines that occurred earlier in the year, there are still significant challenges ahead. How will providers manage the backlog? What will happen to patients’ insurance coverage? How will oncology practices survive and thrive in a post–COVID-19 world? Read More ›

Initiatives to expand patient access programs, strategies to secure the supply chain, and updates on vaccine trials: leaders from top pharmaceutical manufacturers discussed their companies’ ongoing response to the worldwide pandemic in this AVBCC webcast. Read More ›

With many clinical trials on hold and COVID-19 studies the only new trials opening up, how are cancer researchers adapting to the new environment? Can lessons from COVID-19 facilitate improved clinical trial recruitment and retention in the future? Read More ›

Choosing Maintenance Therapy in Ovarian Cancer
Amina Ahmed, MD, Paula Anastasia, RN, MN, AOCN, and Ali McBride, PharmD, discuss the relative benefits and risks of maintenance therapy in ovarian cancer with bevacizumab versus a PARP inhibitor. Read More ›

Page 156 of 298